Tyrosine phosphorylation of SHIP promotes its proteasomal degradation

Exp Hematol. 2010 May;38(5):392-402, 402.e1. doi: 10.1016/j.exphem.2010.03.010. Epub 2010 Mar 18.

Abstract

Objective: The activity of the SH2-containing-phosphatidylinositol-5'-phosphatase (SHIP, also known as SHIP1), a critical hematopoietic-restricted negative regulator of the PI3 kinase (PI3K) pathway, is regulated in large part via its protein levels. We sought to determine the mechanism(s) involved in its downregulation by BCR-ABL and by interleukin (IL)-4.

Materials and methods: We used Ba/F3(p210-tetOFF) cells to study the downregulation of SHIP by BCR-ABL and bone marrow-derived macrophages to study SHIP's downregulation by IL-4.

Results: We show herein that BCR-ABL downregulates SHIP, but not SHIP2 or PTEN, and this can be blocked with the Src kinase inhibitor PP2, which inhibits the tyrosine phosphorylation of SHIP, or with the proteasomal inhibitor MG-132. We also show, using anti-SHIP immunoprecipitates, that c-Cbl and Cbl-b are associated with SHIP and that BCR-ABL induces SHIP's polyubiquitination. This ubiquitination can be blocked with PP2, consistent with the tyrosine phosphorylation of SHIP acting as a signal for its ubiquitination. In bone marrow-derived macrophages, IL-4 also leads to the proteasomal degradation of SHIP but, unlike in Ba/F3(p210-tetOFF) cells, SHIP2 is also proteasomally degraded and the degradation of both inositol phosphatases can be prevented with PP2 or MG-132.

Conclusion: Our results suggest that SHIP protein levels can be reduced via BCR-ABL and/or Src family member-induced tyrosine phosphorylation of SHIP because this triggers its polyubiquitination and degradation within the proteasome.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line / metabolism
  • Crosses, Genetic
  • Down-Regulation
  • Doxycycline / pharmacology
  • Fusion Proteins, bcr-abl / physiology*
  • Humans
  • Inositol Polyphosphate 5-Phosphatases
  • Interleukin-3 / pharmacology
  • Interleukin-4 / pharmacology
  • Lymphocytes / metabolism
  • Macrophages / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • PTEN Phosphohydrolase / genetics
  • PTEN Phosphohydrolase / metabolism
  • Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases
  • Phosphoric Monoester Hydrolases / metabolism*
  • Phosphorylation
  • Phosphotyrosine / metabolism*
  • Proteasome Endopeptidase Complex / metabolism*
  • Protein Processing, Post-Translational*
  • Recombinant Fusion Proteins / physiology
  • Specific Pathogen-Free Organisms
  • src-Family Kinases / deficiency
  • src-Family Kinases / physiology

Substances

  • Interleukin-3
  • Recombinant Fusion Proteins
  • Interleukin-4
  • Phosphotyrosine
  • Fusion Proteins, bcr-abl
  • src-Family Kinases
  • Phosphoric Monoester Hydrolases
  • Inositol Polyphosphate 5-Phosphatases
  • PTEN Phosphohydrolase
  • Pten protein, mouse
  • INPP5D protein, human
  • Inpp5d protein, mouse
  • Inppl1 protein, mouse
  • Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases
  • Proteasome Endopeptidase Complex
  • Doxycycline